Evidence map›Paper›PMID 3359713›Full record

ArticleClinical & experimental metastasis

A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.

T Kalebic, J E Williams, J E Talmadge, C S Kao-Shan, B Kravitz, K Locklear, G P Siegal, L A Liotta, M E Sobel, P S Steeg

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Genomics screens for metastasis genes.Cancer metastasis reviews · 2012
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

T KalebicTumor Invasion and Metastasis Section, National Cancer Institute, Bethesda, Maryland 20892.
J E Williams
J E Talmadge
C S Kao-Shan
B Kravitz
K Locklear
G P Siegal
L A Liotta
M E Sobel
P S Steeg

Funding

MARC TRAINING PROGRAM AT PEMBROKE STATE UNIVERSITYT34GM008037 · NIGMS · UNIVERSITY OF NORTH CAROLINA AT PEMBROKE · PI WORIAX, VELINDA L · 1985 to 2000
$42k
ABNORMAL CARTILAGE DEVELOPMENT: THE BUDR SYSTEMF32HD006423 · NICHD · U.S. NATIONAL INSTITUTES OF HEALTH · PI STEEG, PATRICIA S. · 1985 to 1985
–
NICHD NIH HHS HD06423NIGMS NIH HHS MRC-5T34-GM08037PHS HHS NDI-23910
6 · The paper itself

Abstract

Tumor cell invasion of basement membranes is required at several steps in the process of metastasis. To study the genetic and biochemical events mediating invasion, a variant cell line (TK) was selected from the metastatic M2 K1735 murine melanoma cell line. A novel selection procedure was used, based on in vitro and in vivo invasion and growth upon basement membrane and stroma. Additionally, two extrapulmonary metastases of the TK cell line, TK-Eve and TK-Liver, were established as cell lines and characterized. The TK cell line demonstrates greater metastatic potential in vivo and invasive ability in vitro than the parent M2 cell line, confirming the validity of the selection procedure. In addition, the M2 and TK cell lines were examined for other cell functions involved in the metastatic process. Cellular growth rates and sensitivity to T lymphocyte and natural killer cell lysis were not determining factors in the metastatic potentials of the M2 and selected cell lines; possible macrophage contribution to metastatic behavior was noted. [35S]methionine pulse labeling of protein synthesis and karyotypic analysis confirm the close relationship of parental and selected cell lines.

Indexed as

AnimalsCell DivisionCell LineCytotoxicity, ImmunologicHumansKiller Cells, NaturalKineticsMacrophagesMelanoma, ExperimentalMiceMice, Inbred C3HMice, NudeNeoplasm InvasivenessNeoplasm Metastasis

Identifiers

PMID3359713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.